E. Ohman J:Or Asset Management Ab Esperion Therapeutics, Inc. Transaction History

E. Ohman J:Or Asset Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Apr 05, 2024	SELL	$40.1 - $52.33 $631,093 - $823,569	-15,738 Closed	0 $0
Q1 2019 Apr 05, 2024	SELL	$40.11 - $53.57 $592,464 - $791,282	-14,771 Reduced 48.42%	15,738 $632 Million
Q4 2018 Apr 05, 2024	SELL	$36.99 - $59.11 $1.69 Million - $2.71 Million	-45,768 Reduced 60.0%	30,509 $1.4 Billion
Q3 2018 Apr 05, 2024	BUY	$40.74 - $51.41 $697,468 - $880,139	17,120 Added 28.94%	76,277 $3.38 Billion
Q2 2018 Apr 05, 2024	BUY	$36.2 - $76.4 $2.14 Million - $4.52 Million	59,157 New	59,157 $2.32 Billion

174

125M

2.08M

1.01M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $163M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.